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Abstract Delta (D) 5 desaturase is a key enzyme for the
biosynthesis of health-beneficial long chain polyunsatu-
rated fatty acids such as arachidonic acid (ARA, C20:4n-
6), eicosapentaenoic acid (C20:5n-3) and docosahexaenoic
acid (C22:6n-3) via the ‘‘desaturation and elongation’’
pathways. A full length D5 desaturase gene from Euglena
gracilis (EgD5D) was isolated by cloning the products of
polymerase chain reaction with degenerate oligonucleo-
tides as primers, followed by 50 and 30 rapid amplification
of cDNA ends. The whole coding region of EgD5D was
1,350 nucleotides in length and encoded a polypeptide of
449 amino acids. BlastP search showed that EgD5D has
about 39 % identity with a D5 desaturase of Phaeodacty-
lum tricornutum. In a genetically modified dihomo-
gamma-linoleic acid (DGLA, C20:3n-6) producing Yarrowia
lipolytica strain, EgD5D had strong D5 desaturase activity
with DGLA to ARA conversion of more than 24 %.
Functional dissection of its HPGG and HDASH motifs
demonstrated that both motifs were important, but not
necessary in the exact form as encoded for the enzyme
activity of EgD5D. A double mutant EgD5D-34G158G
with altered sequences within both HPGG and HDASH
motifs was generated and exhibited D5 desaturase activity
similar to the wild type EgD5D. Codon optimization of the
N-terminal region of EgD5D-34G158G and substitution of
the arginine with serine at residue 347 improved substrate
conversion to 27.6 %.
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There is increasing interest in the recognized health ben-
efits of long chain polyunsaturated fatty acids (LC-PUFA)
such as arachidonic acid (ARA, C20:4n-6), eicosapentae-
noic acid (EPA, C20:5n-3) and docosahexaenoic acid
(DHA, C22:6n-3) for both humans and animals [1–3].
Since mammals lack delta (D) 12- and D15-desaturases,
ARA, EPA and DHA cannot be synthesized de novo and
must be obtained either in the diet or synthesized through
‘‘desaturation and elongation’’ pathways (Fig. 1) from
essential fatty acids linoleic acid (LNA, 18:2n-6) and/or
alpha (a)-linolenic acid (ALA 18:3n-3). These LC-PUFA
are important fatty acids for human growth and develop-
ment. For example, ARA, a precursor of EPA, is abundant
in the brain and muscles. As a lipid second messenger ARA
is involved in cellular signaling and is a key inflammatory
intermediate [3]. EPA is a precursor of DHA, and induces a
broad anti-inflammatory response [1–3]. DHA is a major
x-3 fatty acid in the mammalian central nervous system
and enhances synaptic activities in neuronal cells [1–4].
EPA and DHA are the precursors of E- and D-series re-
solvins, respectively. These two classes of resolvins have
distinct structural, biochemical and pharmacological
properties [5, 6]. ARA and DHA together play critical roles
for neurological development and health [4, 7]. Dietary
EPA and DHA can effectively reduce the level of blood
triglycerides in human [8]. Increased intake of EPA-rich
supplement has beneficial effects on coronary heart dis-
ease, high blood pressure, inflammatory disorders and
mental illness [9, 10].
Currently, the primary source of EPA and DHA is
marine fish oil. Most of the EPA and DHA in fish oil are
from their cold-water oceanic microalgae food sources.
More than 85 % of isolated fish oil is used for aquaculture.
In the case of salmon-farming, fish oils from approximately
4 pounds of fish are needed to raise one pound of salmon
filet, the fish-in and fish-out ratio is about 4:1. In today’s
environment, wild-caught fish often contain contaminants
such as methylmercury, polychlorinated biphenyls, dioxins
and several other halogenated persistent organic pollutants
[11]. With ever-growing human populations, and limited
sources of ocean fish, there is growing concern about the
quality, quantity and sustainability of fish oil.
In the last two decades, great efforts have been focused
on developing different hosts for production of LC-PUFA.
Wild type Mortierella alpina has been developed for
commercial production of ARA [12], while Crypthecodi-
nium cohnii and Schizochytrium have been developed for
commercial production of DHA [13]. The ARA and DHA
oils produced from these organisms have been largely used
in infant formulas. Yarrowia lipolytica has been genetically
engineered to contain an EPA biosynthesis pathway [14]
allowing for the commercial production of EPA oil,
NewHarvestTM (http://www.newharvest.com). The EPA oil
has been used as a human nutritional supplement. Additionally,
EPA-rich Yarrowia biomass has been used to feed a brand of
farmed salmon, VerlassoTM (http://www.verlasso.com), with a
fish-in and fish-out ratio of about 1:1. However, the current
production scale and cost of ARA, EPA and DHA cannot meet
the market demand.
Various organisms use different pathways to synthesize
ARA, EPA and DHA. Crypthecodinium and Schizochytri-
um synthesize EPA and DHA through a polyketide-based
pathway [15], while some species of algae, fungi, and
protists synthesize ARA, EPA and DHA through fatty acid
‘‘desaturation and elongation’’ pathways [16, 17]. All
‘‘desaturation and elongation’’ pathways (Fig. 1) require
LNA and/or ALA as a substrate, followed by the ‘‘D9
elongase and D8 desaturase’’ pathway or the ‘‘D6 desat-
urase and C18/20 elongase’’ pathway to synthesize ARA,
EPA and DHA by orchestrated elongation and desaturation
reactions. So far, genetic engineering has mainly employed
these ‘‘desaturation and elongation’’ pathways to modify
hosts such as plants and yeast to produce ARA, EPA and
DHA [14, 18–23]. Production of ARA, EPA and DHA
through ‘‘desaturation and elongation’’ pathways requires
gene expression of D5 desaturase to catalyze the conver-
sion of di-homo-c-linolenic acid (DGLA, C20:3n-6) to
ARA, with a similar activity of converting eicosatetraenoic
acid (ETA, C20:4n-3) to EPA. Since the isolation of D5
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desaturase gene from Mortierella alpina (MaD5D, 24, 25),
several D5 desaturase genes have been isolated [26],
however, there is little research about their structure/
function relationship. Additionally, more efficient D5
desaturase genes are needed to ensure engineered organ-
isms may produce high levels of ARA, EPA and DHA.
D5 desaturases are known as ‘‘front-end’’ desaturases,
wherein desaturation occurs between a pre-existing double
bond and the carboxyl terminus of the fatty acid [26–29].
Like other desaturases, D5 desaturase is an iron-containing
and membrane-bound enzyme that requires both molecular
oxygen and an electron transfer to introduce double bonds
into an existing acyl chain. Microsomal cytochrome b5
serves as electron donor to desaturase enzymes [26, 29,
30]. Fatty acid desaturation can be carried out via con-
certed action of multiple enzymes including NADH
reductase, the desaturase enzyme, and cytochrome b5
reductase. Alternatively, many desaturases contain both a
cytochrome b5 domain and a desaturase domain. For
example, D4, D5, D6 and D8 desaturases have a cyto-
chrome b5 domain at their N-terminus [26]; D9 desaturase
has a cytochrome b5 domain at its C-terminus [30]. The
cytochrome b5 domain of all desaturases has a heme-
binding ‘‘HPGG’’ motif. Previous studies using molecular
dynamics simulations suggest the ‘‘HPGG’’ motif is
important for heme group assembly and desaturase func-
tion [31, 32].
The active site of desaturases has been characterized as
a diiron cluster that is bound to the enzyme by three regions
of highly conserved histidine-rich (His-rich) motifs [27,
30]. These three His-rich motifs H(X)3–4H, H(X)2–3HH,
and H/Q(X)2–3HH are conserved among all front-end
desaturases, and the eight histidine residues of these three
motifs are essential for catalytic activity [33]. In the case of
D5 desaturase from MaD5D [24, 25], the exact amino acid
sequence of the first His-rich motif (H(X)3–4H) is HDASH,
which has been suggested as one of the characteristics of
D5 desaturases and necessary for its function to convert
DGLA to ARA [34]. Recent studies find that several D5
desaturases (GenBank accession #s: AAL82631, AAL13311,
AAL92562, AAM09687, CAJ07076) do not contain the exact
HDASH sequence. Due to the important role of D5 desatu-
rases in LC-PUFA biosynthesis, a detailed understanding of
the functional significance of the conserved HPGG and
HDASH motifs may contribute to improvements in hosts
biologically engineered to produce commercially valuable
LC-PUFA.
We report the isolation of a D5 desaturase gene from
Euglena gracilis (EgD5D). Expression of EgD5D in a
genetically modified DGLA producing Y. lipolytica strain
revealed that EgD5D had strong D5 desaturase activity.
Functional dissection of HPGG and HDASH motifs dem-
onstrated that neither the HPGG nor the HDASH motif is
necessary in the exact form as encoded for enzyme activity
of EgD5D. Various mutants, within HPGG or HDASH
motif alone, or within both HPGG and HDASH motifs, are
functionally equivalent or have higher D5 desaturase
activity than the wild type EgD5D. Codon optimization of
Fig. 1 Biosynthetic pathways
for ARA, EPA and DHA via
‘‘desaturation and elongation’’
pathways
Lipids (2012) 47:913–926 915
123
the N-terminal region of a double mutant EgD5D-
34G158G and substitution of the arginine with serine at
residue 347 effectively improved the enzyme’s substrate
conversion.
Materials and Methods
Strains, Media and Growth Conditions
E. gracilis was kindly provided by Dr. Richard Triemer of
Michigan State University (East Lansing, MI). Euglena
growth (EG) media (per liter): 1 g sodium acetate, 1 g of
beef extract, 2 g of Bacto tryptone and 2 g of Bacto
yeast extract in 970 mL of water. After filter sterilizing,
30 mL of soil–water supernatant was aseptically added. A
1-mL aliquot of E. gracilis culture was transferred into
250 ml of EG Medium in a 500-mL glass bottle. The
cultures were grown at 23 C with a 16 h light, 8 h dark
cycle for 2 weeks with no agitation.
Y. lipolytica strain Y2224 is a 5-fluoroorotic acid (FOA)
resistant mutant of wild type strain American Type Culture
Collection (ATCC, Rockville, MD) #20362 (Fig. 2a) with
a mutation in the URA3 gene (Genbank accession#: No.
AJ306421). Y. lipolytica strain Y4036U (Zhu et al.,
unpublished data) is a genetically modified strain with a
Leu- and Ura- phenotype, also originated from the wild
type strain ATCC #20362. Strain Y4036U produced
approximately 18 % DGLA of total fatty acids (Fig. 2b)
and is composed of heterologous genes encoding D12
desaturase of Fusarium moniliforme [35]; C16/18 elongase
of M. alpina [36]; D9 elongase of E. gracilis [37] and
synthetic mutant of D8 desaturase [38] derived from
E. gracilis. Minimal Media ? Leucine (MMLeu), High
Glucose Media (HGM) and YPD medium were used as
required for Y. lipolytica strains and cultured at 30 C.
MMLeu (per liter): 20 g of glucose; 1.7 g yeast nitrogen
base without amino acids or ammonium sulfate; 0.1 g
proline; 0.1 g leucine; pH 6.1. HGM (per liter): 80 g glu-
cose, 2.58 g KH2PO4, 5.36 g K2HPO4, pH 7.5. YPD
medium (per liter): 10 g of yeast extract, 20 g of Bacto
peptone, and 20 g of glucose. Agar plates were prepared by
addition of 20 g/l agar to liquid media.
General Techniques for Molecular Biology
Recombinant DNA techniques were used according to
standard methods [39, 40]. Site-directed mutagenesis was
performed according to the manufacturer’s protocol
(QuikChangeTM, Stratagene; San Diego, CA). When PCR
or site-directed mutagenesis was involved in the generation
of mutants and/or cloning, DNA was sequenced to verify
that no additional mutations were introduced.
Total RNA was extracted from the E. gracilis cells using
the RNA STAT-60TM reagent (Amsbio LLC., Lake forest,
CA). 85 lg of mRNA was purified from 1 mg of total RNA
using the mRNA Purification Kit (Amersham Biosciences,
Piscataway, NJ). Synthesis of cDNA from the E. gracilis
mRNA was carried out using the adapter primer AP of
30-RACE kit from Invitrogen (Carlsbad, CA) and the Smart
IV oligonucleotide of BD-Clontech CreatorTM SmartTM
cDNA library kit (Mississauga, ON, Canada) as primers.
The reverse transcription was performed with Superscript
II reverse transcriptase of Invitrogen.
PCR reactions were carried out in a 50 ll total volume
comprising: PCR buffer (containing 10 mM KCl, 10 mM
(NH4)2SO4, 20 mM Tris–HCl (pH 8.75), 2 mM MgSO4,
0.1 % Triton X-100), 100 lg/mL BSA, 200 lM each
deoxyribonucleotide triphosphate, 10 pmol of each primer,
10 ng cDNA of E. gracilis and 1 ll of Taq DNA poly-
merase (Epicentre Technologies, Madison, WI). The ther-
mocycler conditions were set for 35 cycles at 95 C for
1 min, 56 C for 30 s and 72 C for 1 min, followed by a
final extension at 72 C for 10 min. The DNA band with
expected size was isolated from a 1 % agarose gel and
cloned into pGEM-T easy vector (Promega, Madison, WI.).
Modified 50 and 30 RACE techniques were used to
obtain the full length EgD5D. The cDNA product from
E. gracilis mRNA was used as template, and all the primers
used in the 50 and 30 RACE are listed in Supplemental




Fig. 2 Chromatograms of the fatty acid profiles. Fatty acid profile of
wild type Y. lipolytica strain ATCC#20362 (a). Fatty acid profile
of Y4036U strain, producing about 8 % HGLA (b). Fatty acid profile
of Y4036U strain transformed with pDMW367-M4, producing about
3.7 % ARA of total lipids (c)
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and a generic primer CDSIII 50 were used in the first round
of 50 RACE. The PCR amplifications were carried out in a
50 ll total volume, comprising: 25 ll of LA TaqTM pre-
mix (TaKaRa Bio Inc., Otsu, Shiga, 520-2193, Japan),
10 pmol of each primer and 1 ll of Taq DNA polymerase
(Epicentre Technologies, Madison, WI). The thermocycler
conditions were the same as described above. One micro
liter of this product was directly used in a second ampli-
fication, which differed from the first only in that the
primers used, ODMWP479 and the generic primer DNR
CDS 50 were internal to the first set of primers. As no
translation initiation codon was found in the product of the
first round of 50 RACE, the entire modified 50 RACE
protocol was repeated using gene specific primers YL791
and YL792 as primers instead of the primers used in the
first round.
A variation of a 30 RACE technique was used to isolate
the C-terminal fragment of EgD5D. The combinations of
primers ODMW469 and AUAP, and then YL470 and
AUAP were used in the initial amplification and second
round reaction, respectively. The PCR reactions were the
same as those described for the 50 RACE.
Yarrowia Expression Vector and Transformation
Yarrowia expression vector pDMW367 contained autono-
mous replication sequence 18 [41] and a URA3 gene
(Genbank accession#: No. AJ306421) of Y. lipolytica. It
also contains a FBAIN::EgD5D:Pex20 chimeric gene. The
FBAIN is a promoter derived from the fructose-bisphos-
phate aldolase gene (FBA1) of Y. lipolytica [42]. The
EgD5D is the coding region of a wild type D5 desaturase of
E. gracilis, in which the amino acid at position 347 is
arginine. The Pex20 was a terminator sequence of PEX20
gene (Genbank accession#: AF054613) of Y. lipolytica.
Transformation of Y. lipolytica strain Y4036U was carried
out as described by Chen et al. [43].
Cultivation of Y. lipolytica Transformants and Fatty
Acid Analysis by Gas Chromatography
The Yarrowia expression plasmid and its derivatives were
used to transform strain Y4036U individually. Transfor-
mants from each transformation were streaked onto new
MMLeu plates and kept in a 30 C incubator for 2 days.
Cells from streaked plates were cultivated in 24 well blocks
with 3 mL MMLeu, and incubated for 2 days at 30 C with
shaking at 200 rpm. The cells were then collected by
centrifugation and resuspended in 3 mL HGM. The cells
were incubated another 5 days at 30 C with shaking at
200 rpm.
Fatty acid methyl esters from 1 ml cell culture of
Y. lipolytica or E. gracilis were prepared as described [44],
except that the fatty acid methyl esters were extracted with
0.5 ml of heptane and separated by Agilent 7890A GC
using hydrogen as carrier gas supplied by a hydrogen
generator (Parker Hannifin, Cleveland, OH). The oven
temperature was programmed from 200 to 240 C at a rate
of 25 C/min. The proportion of each fatty acid was based
on the integrated peak area of the corresponding fatty acid
methyl ester as a percent relative to the sum of all inte-
grated peaks as calculated by Agilent ChemStation
Software.
Results
Isolation of D5 Desaturase Gene from E. gracilis
Fatty acid profile analyses showed that there were moder-
ate amounts of EDA, DGLA, ARA, EPA, docosapentae-
noic acid (DPA 22:5n-3) and DHA produced in E. gracilis
(data not shown), confirming that there was a ‘‘D9 elong-
ase/D8 desaturase’’ pathway in E. gracilis [16, 38, 45]. The
genes encoding the D9 elongase, D8 desaturase [16, 38],
D5 desaturase, D17 desaturase, C20/22 elongase and D4
desaturase [45] were responsible for the production of
EDA, DGLA, ARA, EPA, DPA and DHA, respectively
(Fig. 1).
After comparison of four D5 desaturase genes, PiD5D
from Pythium irregulare [46], PmD5D from Phytophthora
megasperma (Genbank accession #: CAD53323), PtD5D
from Phaeodactylum tricornutum [47], and DdD5D
from Dictyostelium discoideum (Genbank accession #:
XP_640331) as well as two D8 desaturase genes, EgD8D
from E. gracilis [16, 38] and PlD8D from Pavlova lutheri
[48], two conserved regions, GHH(I/V)YTN and N(Y/
F)Q(V/I)EHH (Fig. 3) were selected to design primers to
amplify a portion of EgD5D. To reduce the degeneracy of
the primers, four primers (Supplemental Table S1: 5-1A to
1D) were generated for conserved region 1 and four
primers (Supplemental Table S1: 5-5AR to 5-5DR) for the
anti-sense strand of conserved region 2. One DNA frag-
ment amplified with primers 5-1B and 5-5DR was cloned
into pGEM-T Easy vector to generate pT-F10-1. DNA
sequence showed that a 590 bp insert of pT-F10-1 encoded
an amino acid sequence with 38 % identity and 53 %
similarity to the amino acid sequence of the D8-sphingo-
lipid desaturase of Thalassiosira pseudonana (TsD8D,
Genbank accession #: AAX14502), and 37 % identity and
52 % similarity with PtD5D [47]. These data suggested
that the 590 bp DNA fragment might be a part of a
desaturase gene of E. gracilis. This gene was designated as
putative EgD5D.
50 and 30 RACE techniques were used to extend the
590 bp region of the putative EgD5D (Fig. 4). A 797 bp
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DNA fragment with no translation initiation codon was
isolated by the first round of 50 RACE. This 797 bp DNA
fragment had a 238 bp overlap with the 50 end of the
590 bp fragment of pT-F10-1 and provided 559 bp of 50
upstream sequence. A 273 bp DNA fragment was gener-
ated by the second round 50 RACE experiment. This
273 bp DNA fragment had 253 bp overlap with the 50 part
of the 797 bp DNA fragment and provided 20 bp of 50
upstream sequence. Seventeen [17] bp of the 20 bp enco-
ded the N-terminal portion of the putative EgD5D,
including the translation initiation codon. A 464 bp DNA
sequence was identified by one round of 30 RACE. The first
184 bp of the 464 bp fragment encoded the C-terminal
coding region, including the translation stop codon, of the
putative EgD5D.
Assembly of the 50 region, the original 590 bp fragment
and the 30 region resulted in a 1,633 bp contig, comprising
the complete coding region with additional untranslated 50
and 30 ends (Fig. 4). The coding region of the putative
EgD5D is 1,350 bp in length and encodes a peptide of 449
amino acids. BlastP searches using the full length putative
EgD5D as the query sequence showed that it shares 39 %
identity and 56 % similarity with PtD5D [47]; 37 %
identity and 55 % similarity with TsD8D (Genbank
accession #: AAX14502). Amino acid sequence alignment
performed with the Clustal W analysis (MegAlignTM
program of DNASTAR software) showed that EgD5D has
\30 % identity with some represent D5 desaturases such
as IgD5D from I. galbana (AEA72469); MaD5D from
M. alpina [24, 25, 34]; PiD5D [46]; OtD5D from O. tauri
(Genbank accession #: XP_003082424) and TaD5D from
T. aureum [49]. Further analyses showed that EgD5D has
only 20 % and 25.5 % identity with EgD8D [16] and
EgD4D [45] desaturases of E. gracilis, respectively. It was
found that the PCR products for the full length coding
region of putative EgD5D had two versions, both having
identical nucleotide sequence except at base pair positions
1,039 and 1,041. This disagreement resulted in a codon
change from CGA to AGC. As such, one PCR product
indicated arginine at position 347, whereas the second
indicated serine. It was hypothesized that this discrepancy
was raised at the stage of PCR amplification or during
cDNA generation.
Determination of D5 Desaturase Activity and Topology
Model of EgD5D
To study the function of the putative EgD5D, plasmid
pDMW367 was generated to express the EgD5D coding
region under the control of the strong constitutive FBAIN
promoter [42] from Y. lipolytica. The four restriction sites
(i.e., BglII, EcoRI, HindIII and NcoI) inside the coding
region of EgD5D in pDMW367 were removed by site-
directed mutagenesis to generate pDMW367-M4 (Supple-
mental Fig. S1). The amino acid sequence of EgD5D is
identical in pDMW367 and pDMW367-M4 constructs, and
the amino acid at position 347 is an arginine.
The pDMW367 and pDMW367-M4 constructs were
used to transform DGLA producing strain Y4036U. There
was no ARA produced in the parent strain Y4036U
(Fig. 2b), while there was about 3.7 % ARA and 11.5 %
DGLA produced in transformants of Y4036U with either
Fig. 4 Graphical representation of the assembly of full length
EgD5D. A 590 bp DNA fragment encoding a portion of EgD5D
was isolated by PCR amplification with degenerate primers. The
N-terminal part was isolated by two round of 50 RACE, and the
C-terminal portion was isolated by one round of 30 RACE
B
A
Fig. 3 Alignment of the conserved regions among some D5 and D8
desaturases. The amino acid sequence alignment was performed with
Clustal W analysis (MegAlignTM program of DNASTAR software).
Identical residues are shaded in black. PtD5D, D5 desaturase from
P. tricornutum (29, GenBank accession #: AAL92562); PmD5D, D5
desaturase from P. megasperma (GenBank accession #: CAD53323);
PiD5D, D5 desaturase from P. irregulare (30, GenBack accession #:
AAL13311); DdD5D, D5 desaturase from D. discoideum (GenBack
accession #: XP_640311); EgD8D, D8 desaturase from E. gracilis
(24, GenBack accession #: AAD45877) and PvD8D, D8 desaturase
from P. lutheri [48]
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the pDMW367 or pDMW367-M4 construct (Fig. 2c).
These results demonstrated that EgD5D indeed encodes a
D5 desaturase. EgD5D could convert DGLA to ARA with a
conversion of about 24.3 %. The conversion of DGLA to
ARA was calculated according to the formula: ([ARA
product]/[DGLA substrate ? ARA product]). The pDMW367
and pDMW367-M4 constructs were also used to transform
strain Y2224, a FOA resistant mutant of wild type strain
ATCC#20362. There was no GLA produced in the trans-
formants with either the pDMW367 or pDMW367-M4
construct (data not shown). These results demonstrated that
EgD5D does not have D6 desaturase activity; it is not a bi-
functional enzyme.
Like other fatty acid desaturases, EgD5D is also a
membrane-bound enzyme and belongs to a super-family
of membrane di-iron proteins with three His-rich motifs:
HX(3, 4)H, HX(2, 3)HH and (H/Q)X(2, 3)HH. These His resi-
dues have been predicted to be located in the cytoplasmic
face of the membrane and have been shown to be very
important for enzyme activity [33]. Within EgD5D, these 3
His-rich motifs are the HDASH motif located from residue
155 to 159, the HIMRHH motif located from residue 190 to
195, and the QIEHH motif located from residue 385 to 389.
The third His-rich motif contains a glutamine substitution
that is common to other front-end desaturases. Based
on transmembrane domain analysis (TMHMM Server v. 2.0,
Center for Biological Sequence Analysis, BioCentrum-
DTU, Technical University of Denmark, DK-2800 Lyngby,
Denmark) and the location of the His-rich motifs, a topology
model of EgD5D was developed (Fig. 5). The model shows
that the N-terminal cytochrome b5 domain is located in the
cytosol. The topology model also predicts that EgD5D has
a total of four transmembrane regions (amino acid resi-
dues 103–125, 130–152, 280–302 and 306–328) and two
hydrophobic regions (amino acid residues 165–187, and
234–256). These hydrophobic segments are not membrane-
spanning, and may represent hydrophobic patches located
closed to the di-iron active site. Because the substrates for
the desaturase is highly hydrophobic, they will likely par-
tition into the lipid bilayer. Therefore we purport that the
di-iron active site assembled from these His-clusters may
occur at or very near the membrane surface.
The HPGG Motif is Important, but not Necessary
for D5 Desaturase Activity of EgD5D
It has been suggested that the highly conserved HPGG
motif plays a crucial role in heme group assembly, protein
folding and stabilization in cytochrome b5 proteins, with
the histidine residue functioning as an axial heme ligand
where a peptide chain reversal occurs [50]. Previous
studies have demonstrated that the heme-binding HPGG
motif, and in particular, the histidine residue, is essential
for enzyme activity of desaturases with cytochrome b5
domain [51–53]. Although sequence divergence in the
vicinity of the HPGG motif is normal, the HPGG motif
itself has been conserved throughout the evolution of all
the D5 desaturase genes [54]. Thus it was claimed to be a
characteristic of D5 desaturases and necessary for its
function to convert DGLA to ARA [34].
To assess the functional significance of the HPGG motif
(position 33–36) of EgD5D, we first elected the proline
Fig. 5 Topology model of EgD5D. EgD5D is a membrane diiron
protein with three His-rich motifs. The HX(3, 4)H motif, HDASH, is
located from residues 155 to 159; the HX(2, 3)HH motif, HIMRHH,
located from residues 190 to 195, and the (H/Q)X(2, 3)HH motif,
QIEHH, located from residues 385 to 389. EgD5D has four trans-
membrane domains (I–IV) and two hydrophobic stretches (residues
from 165 to 187, and 234 to 256). Its N-terminal cytochrome b5
domain and C-terminal region are located in the cytoplasm
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residue at position 34 (P34) as a target for amino acid
substitution. Single amino acid mutations were carried out
to generate all 19 amino acid substitution mutants (HxGG).
Table 1 shows that the P34 residue could be substituted
with several different amino acids without significantly
impacting the D5 desaturase activity of EgD5D. The
EgD5D-34A, EgD5D-34C, EgD5D-34K or EgD5D-34W
mutants exhibited[90 % of the wild type EgD5D activity.
The EgD5D-34G mutant was functionally equivalent to the
wild type EgD5D.
Next, we studied the significance of the second glycine
residue at position 36 (G36) within the HPGG motif of
EgD5D using the same approach as that for P34. Table 2
shows that the G36 residue within the HPGG motif could
be substituted with several different amino acids without
significantly impacting the D5 desaturase activity of
EgD5D. The EgD5D-36S or EgD5D-36D mutant had about
100.8 or 99.2 % of D5 desaturase activity when compared
to EgD5D, respectively.
The above functional studies at the P34 and G36 posi-
tions within the HPGG motif of EgD5D demonstrated that
the HPGG motif could be changed without impacting the
D5 desaturase activity. Specifically, the EgD5D-34G,
EgD5D-36S and EgD5D-36D mutants were functionally
equivalent to the wild type EgD5D. Comparison of the
ARA in unesterified fatty acid (FFA), phospholipid (PL)
and neutral lipid (NL) pools of Yarrowia transformants
with EgD5D and EgD5D-34G showed that the P34G
mutation did not affect the ARA distribution in these pools
(Supplemental Fig. S2).
Improvement of D5 Desaturase Activity of EgD5D
by Amino Acid Substitution Within the HDASH Motif
The HDASH motif was also claimed as one of the char-
acteristics of D5 desaturases and necessary for its function
to convert DGLA to ARA [34]. To test the hypothesis that
the exact sequence of the HDASH motif (position
155–159) of EgD5D was required, we first selected the
alanine residue at position 157 (A157) as a target. The D5
desaturase activity attributed to each mutation at A157 is
summarized in Table 3. The data showed that almost all
mutations at A157 greatly reduced the D5 desaturase
activity of EgD5D. However, the EgD5D-157G and
EgD5D-157S mutants retained about 96 and 94 % activity
of wild type EgD5D, respectively.
We also studied the significance of the serine residue at
position 158 (S158) within the HDASH motif of EgD5D.
Table 4 shows that the S158 could be substituted with
either an alanine or a glycine without substantially
Table 1 D5 Desaturase activity of EgD5D with HxGG mutations









EgD5D HPGG 24.2 100
EgD5D-34A HaGG 22.7 93.5
EgD5D-34C HcGG 22.6 93.2
EgD5D-34D HdGG 12.5 51.6
EgD5D-34E HeGG 14.7 60.5
EgD5D-34F HfGG 17.9 73.9
EgD5D-34G HgGG 23.8 98.2
EgD5D-34H HhGG 21.3 87.8
EgD5D-34I HiGG 18.3 75.4
EgD5D-34K HkGG 22.7 93.8
EgD5D-34L HlGG 17.0 70.0
EgD5D-34M HmGG 19.0 78.4
EgD5D-34N HnGG 19.8 81.5
EgD5D-34Q HqGG 19.8 81.7
EgD5D-34R HrGG 19.4 79.9
EgD5D-34S HsGG 20.4 84.1
EgD5D-34T HtGG 19.6 80.7
EgD5D-34V HvGG 20.2 83.4
EgD5D-34W HwGG 22.2 91.7
EgD5D-34Y HyGG 17.7 73.1
Average of 6 samples for each construct containing different
mutations
Table 2 D5 Desaturase activity of EgD5D with HPGx mutations









EgD5D HPGG 24.2 100
EgD5D-36A HPGa 18.3 75.6
EgD5D-36C HPGc 6.5 26.8
EgD5D-36D HPGd 24.0 99.2
EgD5D-36E HPGe 21.1 86.9
EgD5D-36F HPGf 3.3 13.4
EgD5D-36H HPGh 18.1 74.8
EgD5D-36I HPGi 1.5 6.4
EgD5D-36K HPGk 19.0 78.3
EgD5D-36L HPGl 9.1 37.7
EgD5D-36M HPGm 13.4 55.2
EgD5D-36N HPGn 19.5 80.3
EgD5D-36P HPGp 18.0 74.1
EgD5D-36Q HPGq 19.9 82.1
EgD5D-36R HPGr 15.5 63.8
EgD5D-36S HPGs 24.4 100.8
EgD5D-36T HPGt 22.8 93.9
EgD5D-36V HPGv 1.9 8.0
EgD5D-36W HPGw 15.1 62.2
EgD5D-36Y HPGy 11.2 46.3
Average of 6 samples for each construct containing different
mutations
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impacting the D5 desaturase activity of EgD5D. Specifi-
cally, the EgD5D-158A mutant had about 100.9 % activity
of wild type EgD5D, while the EgD5D-158G mutation had
about 107.7 % activity of wild type EgD5D. These data
demonstrated that the HDASH motif could be changed
without significantly reducing the D5 desaturase activity. In
fact, the enzyme activity of EgD5D could be improved by
substitution of the S158 within the HDASH motif with a
glycine residue.
Both HPGG and HDASH Motifs were not Necessary
in the Exact Form as Encoded for D5 Desaturase
Activity of EgD5D
In order to study whether EgD5D could maintain strong D5
desaturase activity with mutations in both HPGG and
HDASH motifs, we generated a series of double mutants.
The results (Table 5) demonstrate that D5 desaturases
could be constructed having variant HPGG and HDASH
motifs that retain at least 64 % of D5 desaturase activity
when compared to the wild type.
The proline residue within the HPGG motif can be
substituted with glycine with simultaneous substitution of
either (1) the alanine residue within the HDASH motif for
glycine or (2) the serine residue within the HDASH motif
for alanine or glycine. The proline residue within the
HPGG motif can also be substituted with histidine with
simultaneous substitution of the serine residue within the
HDASH motif for either alanine or glycine. And, the sec-
ond glycine residue within the HPGG motif can be
substituted with serine with simultaneous substitution of
the serine residue within the HDASH motif for either
alanine or glycine. Specifically, the EgD5D-34G/157G,
EgD5D-34G/158A and EgD5D-34H/158G double mutants
had more than 80 % of the D5 desaturase activity of
EgD5D, while EgD5D-34G/158G had about 97 % D5
desaturase activity of EgD5D. Further analyses showed that
the ARA distribution in FFA, PL and NL pools of Yarr-
owia transformants with EgD5D-34G/158G was similar to
Yarrowia transformants with EgD5D-34G or EgD5D
(Supplemental Fig. S2), suggesting that the simultaneous
substitutions (P34G and S158G) within HPGG and
HDASH motifs did not change desaturase substrate
specificity.
Increased Substrate Conversion of EgD5D-34G/158G
with Double Mutations in HPGG and HDASH Motifs
In order to increase the substrate conversion of EgD5D-
34G/158G, we optimized the codon usage of the
Table 3 D5 Desaturase activity of EgD5D with HDxSH mutations









EgD5D HDASH 24.8 100
EgD5D-157C HDcSH 10.7 43.1
EgD5D-157D HDdSH 1.0 4.0
EgD5D-157E HDeSH 0.9 3.6
EgD5D-157F HDfSH 1.0 4.0
EgD5D-157G HDgSH 23.8 96
EgD5D-157H HDhSH 1.0 4.0
EgD5D-157I HDiSH 0.9 3.6
EgD5D-157K HDkSH 1.0 4.0
EgD5D-157L HDlSH 1.1 4.4
EgD5D-157M HDmSH 1.0 4.0
EgD5D-157N HDnSH 1.1 4.4
EgD5D-157P HDpSH 2.3 9.3
EgD5D-157Q HDqSH 0.6 2.4
EgD5D-157R HDrSH 0.8 3.2
EgD5D-157S HDsSH 23.3 94
EgD5D-157T HDtSH 1.0 4.0
EgD5D-157V HDvSH 0.3 1.2
EgD5D-157W HDwSH 0.9 3.6
EgD5D-157Y HDySH 0.7 2.8
Average of 3 samples for each construct containing different
mutations
Table 4 D5 Desaturase activity of EgD5D with HDAxH mutations









EgD5D HDASH 23.3 100
EgD5D-158A HDAaH 23.5 100.9
EgD5D-158C HDAcH 17.9 76.8
EgD5D-158D HDAdH 2.8 12.0
EgD5D-158E HDAeH 1.9 8.2
EgD5D-158F HDAfH 1 4.3
EgD5D-158G HDAgH 25.1 107.7
EgD5D-158H HDAhH 1.6 6.9
EgD5D-158I HDAiH 1.1 4.7
EgD5D-158K HDAkH 1 4.3
EgD5D-158L HDAlH 1.1 4.7
EgD5D-158M HDAmH 2.3 9.9
EgD5D-158N HDAnH 16.5 70.8
EgD5D-158P HDApH 1.2 5.2
EgD5D-158Q HDAqH 10.4 44.6
EgD5D-158R HDArH 10.0 42.9
EgD5D-158T HDAtH 9.6 41.2
EgD5D-158V HDAvH 1.5 6.4
EgD5D-158W HDAwH 9.3 40.0
EgD5D-158Y HDAyH 1.1 4.7
Average of 3 samples for each construct containing different
mutations
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N-terminal portion of the gene for expression in Y. li-
polytica. The codon-optimized EgD5D-34G/158G, desig-
nated as ‘‘EgD5M’’, had 48 bp changed in the first 204 bp
of the coding region (23.5 %; Fig. 6), which resulted in
optimization of 43 codons of the first 68 amino acids within
the N-terminus of the protein (63.2 %). The amino acid
sequence encoded by the codon-optimized EgD5M was
identical to that of the EgD5D-34G/158G. EgD5M was
used to replace the EgD5D of pDMW367-M4 to gener-
ate pDMW367-5M, containing a FBAIN::EgD5M::Pex20
chimeric gene.
We then studied the importance of the arginine or serine
at position 347 that were found in the original clones of
EgD5D. Based on EgD5M, the CGA codon for arginine at
position 347 was changed to AGC codon to encode for
serine, which was designated as EgD5M1. The synthetic
EgD5M1 was used to replace the EgD5D of pDMW367-
M4 to generate pDMW367-5M1, containing an FBAIN::
EgD5M1::Pex20 chimeric gene.
The D5 desaturase activity of EgD5D, EgD5M and
EgD5M1 is summarized in Table 6. GC analyses deter-
mined that there were about 3.6 % ARA and 10.8 %
DGLA, 4.0 % ARA and 11.2 % DGLA, and 4.1 % ARA
and 10.8 % DGLA of total fatty acids produced in the
Yarrowia transformants with pDMW367-M4, pDMW367-
5M, and pDMW367-5M1, respectively. It showed that the
wild-type EgD5D converted about 24.8 % of DGLA to
ARA; EgD5M converted 26.7 % of DGLA to ARA; and,
EgD5M1 converted 27.6 % of DGLA to ARA. The fatty
acid profile of Yarrowia transformants with EgD5M1 was
almost identical to the profile of Yarrowia transformants
with pDMW367-M4 as shown in Fig. 2c, except that more
ARA was produced. These data demonstrated that the
codon optimization of EgD5D improved its substrate con-
version efficiency. Further, the amino acid at position 347
did affect the D5 desaturase activity of EgD5D, with a
serine residue preferred over an arginine residue.
Discussion
Y. lipolytica has an established history of robust fermen-
tation performance at commercial scale for processes
including the production of food-grade citric acid for
human consumption and single-cell protein for animal
feeds [55]. Recently, Y. lipolytica has been used as a host
for production of lipid-based compounds [14, 56, 57].
Some Y. lipolytica strains are oleaginous organisms that are
able to accumulate up to 40 % dry cell weight as oil when
starved for nitrogen in the presence of excess glucose as
carbon source. However, LNA is the only PUFA that
Y. lipolytica can synthesize de novo (Fig. 2a). Therefore, it
Table 5 D5 Desaturase activity of EgD5D with mutants simulta-
neously comprising mutations within HPGG and HDASH motifs












EgD5D HPGG HDASH 27.5 100
EgD5D-
34G157G
HgGG HDgSH 22.9 83
EgD5D-
34G158A
HgGG HDAaH 24.3 88
EgD5D-
34G158G
HgGG HDAgH 26.8 97
EgD5D-
34H158A
HhGG HDAaH 18.7 68
EgD5D-
34H158A
HhGG HDAgH 22 80
EgD5D-
36S158A
HPGs HDAaH 17.5 64
EgD5D-
36S158G
HPGs HDAgH 18.9 69
Average of 6 samples for each construct containing different
mutations
Fig. 6 Comparison of the 50 portion (204 bp) of EgD5D-34G158G
and its codon optimized version, EgD5M. The DNA sequence
alignment was performed with Clustal W analysis (MegAlignTM
program of DNASTAR software). Identical residues are shaded in
black














EgD5D HPGG HDASH R 24.8
EgD5M HgGG HDAgH R 26.5
EgD5M1 HgGG HDAgH S 27.6
Average of 6 samples for each construct containing different
mutations
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is necessary to isolate genes encoding enzymes for every
step of the ‘‘desaturation and elongation’’ pathways
(Fig. 1) before genetically engineering Y. lipolytica to
produce ARA, EPA and DHA oil. D5 desaturase is the
enzyme responsible for the conversion of DGLA to ARA,
and ETA to EPA. Although several D5 desaturase genes
have been isolated from various organisms [26], more
effective enzymes may help to improve the production of
commercially important LC-PUFA.
Previous studies have indicated that Euglena was able to
synthesize ARA, EPA and DHA through the ‘‘D9 elongase/
D8 desaturase’’ pathway [16, 38, 45]. In this report, the
gene encoding a D5 desaturase from E. gracilis was iso-
lated and characterized. Our results indicated two nucleo-
tide sequences with a difference of two base pairs that
would result in either arginine or serine at position 347.
This discrepancy was most likely generated from PCR
amplification or during cDNA generation. BlastP searches
showed that the amino acid sequence of EgD5D shares
\40 % identity with any D5 desaturase found in Genbank;
PtD5D [47] was the most similar one (about 39 %),
suggesting that the primary structure of EgDD5 is quite
different from those D5 desaturase genes previously isolated.
Amino acid sequence alignment also shows that EgD5D
has about 20 % identity with EgD8D [16, 38] and about
25.5 % identity with EgD4D [45]. These data suggest that
EgD5D is evolutionary closer to D5 desaturase than the
D4 or D8 desaturases. Functional analyses of EgD5D in
Y. lipolytica strains Y4036U and Y2224 revealed that it has
strong D5 desaturase activity, with more than 24 % sub-
strate conversion of DGLA to ARA, and it is not a D5/D6
bifunctional enzyme.
The HPGG motif is expected to be on the cytochrome b5
surface, in contact with the heme through van der Waals
interactions [27]. The conserved HPGG motif was thought
to be essential in maintaining cytochrome b5 electron
transfer function, with the histidine serving as a heme axial
ligand [50]. Substitution of the histidine residue of the
HPGG motif with alanine in the D6 desaturase cytochrome
b5 domain of starflower, rat and algae abolished D6
desaturase activity [51–53]. It is expected that H33 of
EgD5D should also be essential for its function.
The HPGG motif itself has a unique structure. The
proline residue of the HPGG stretch is located in a turn
between two consecutive helices (Fig. 5) and was thought
to be important in protein folding and in maintaining
cytochrome b5 protein stability [32]. The three-carbon side
chain of proline is bonded to both the nitrogen and the
carbon of the peptide backbone to form a five-member ring
that greatly restricted its conformational freedom. The
nonpolar characteristic of this ring structure may create a
hydrophobic spot within the HPGG motif. On the other
hand, the glycine possesses the smallest amino acid side
chain, hydrogen, which can allow for greater flexibility in
local structure. It is likely that the combination of proline
and glycine residues within the cytochrome b5 HPGG motif
is an important factor affecting both the structural position
of the hydrophobic heme pocket and the appropriate ori-
entation of the heme group within the heme pocket relative
to the desaturase catalytic site. Surprisingly, our results
indicate that the proline residue of the HPGG motif is not
essential for electron transfer from the heme group of the
cytochrome b5 domain to the catalytic diiron cluster of
EgD5D. Most substitution mutants at P34 displayed at least
70 % of the wild type EgD5D activity. The EgD5D-34G
(HgGG) mutant had greater than 98 % of the wild type
EgD5D activity, demonstrating that the proline residue of
HPGG motif is not required for the enzyme activity of
EgD5D (Table 1).
It is noteworthy that aspartate substitutions in EgD5D-
34D and EgD5D-36D exhibit different effects on desatur-
ase activity. Compared to free cytochrome b5, while there
are several conserved acidic amino acids, there is a char-
acteristic reduction in the number of aspartate and gluta-
mate residues in the vicinity of the HPGG motif of
cytochrome b5 domain of desaturases. This reduced num-
ber of acidic residues around the heme pocket is thought to
contribute to stabilizing nonpolar intermolecular interac-
tions between the cytochrome b5 and desaturase domains
[27, 54]. Substitutions involving aspartate or glutamate
residues in the HPGG motif may affect the interface
geometry of electron donor/acceptor docking that is
exhibited in desaturase activity due to altered electron
transfer. We also found that substitutions for G36 of
EgD5D resulted in mutants with strong D5 desaturase
activity. The most functional mutants were the small,
slightly polar serine replacement, EgD5D-36S, and the
acidic substitution with aspartate, EgD5D-36D. The activ-
ities of these two mutants are about the same as the wild
type EgD5D (Table 2).
The amino acid sequence of the first His-rich motif,
HX(3, 4)H, of EgD5D is HDASH located from residues 155
to 159. The HDASH motif has been suggested as one of the
characteristics of D5 desaturases and necessary for its
function to convert DGLA to ARA in any transformed
organisms [34]. Sequence analyses showed that there are
natural variants of the HDASH motif in D5 desaturases,
for example, PiD5D [46] has the sequence of HDsSH, the
D5 desaturase from Thraustochytrium sp. ATCC 21685
(GenBank accession #: AAM09687) has the sequence
of HemgH, the D5 desaturase from Leishmania major
strain Friedlin (GenBank accession #: CAJ07076) has the
sequence of HeAgH, the D5 desaturase from Atlantic sal-
mon (GenBank accession #: AAL82631) has the sequence
of HDygH, and PtD5D [47] has the sequence of HDAnH in
the corresponding location. This suggests that the HDASH
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motif is not an invariant characteristic of D5 desaturases,
and may be not required for D5 desaturase activity. We
suggest that the two His residues of HDASH motif par-
ticipate in the coordination of the diiron center (Fig. 5), but
the other three residues (DAS) residues between the two
His residues can be modified.
Systemic substitution studies (Tables 3, 4) at positions
A157 and S158 within the HDASH motif of EgD5D
demonstrated that these two residues could be replaced,
and the mutants retained good D5 desaturase activity. The
EgD5D-157G and EgD5D-157S mutants had about 96 and
94 % of the wild type EgD5D activity, respectively. Since
PiD5D has an HDsSH motif [46], it is not surprising that
EgD5D-157S with sequence HDsSH functioned well in
Yarrowia. We also found that S158 could be substituted
with either alanine or glycine. The alanine, glycine and
serine are interchangeable within the HDASH motif of
EgD5S; furthermore, the enzyme activity of EgD5D could
be improved with a motif of HDAgH instead of HDASH
(Table 4).
To determine whether at least one motif, HPGG or
HDASH, is required for the enzyme activity of EgD5D, a
series of mutants with mutations in both the HPGG and
HDASH motifs was generated (Table 5). Some double
mutants such as EgD5D-34G/157G, EgD5D-34G/158A and
EgD5D-34H/158G had more than 80 % of wild type
EgD5D activity, while EgD5D-34G/158G had almost the
same activity as wild type EgD5D. Therefore, neither the
HPGG nor the HDASH motif is necessary in the exact form
as encoded for the activity of EgD5D.
Distribution analyses (Supplemental Fig. S2) of ARA in
FFA, PL and NL pools of Yarrowia transformants with
EgD5D shows that more ARA loaded in PL pool than that
in FFA pool, suggesting that EgD5D is also an acyl-lipid
desaturase, just like other front-end desaturases from lower
plants, fungi and algae [26]. ARA distribution comparison
of Yarrowia transformants with EgD5D-34G and EgD5D-
34G/158G with wild type EgD5D shows that either single
mutation within HPGG motif (P34G), or simultaneous
mutations within HPGG (P34G) and HDASH (S158G)
motifs does not change its fatty acid distribution pattern
(Supplemental Fig. S2), and therefore these changes in
EgD5D do not affect its substrate specificity.
An effective D5 desaturase is required for efficient
conversion of DGLA to ARA or ETA to EPA (Fig. 1) in
engineered Y. lipolytica or other organisms to produce
commercially valuable LC-PUFA. We employed two
approaches to improve the enzyme activity of the double
mutant EgD5D-34G/158G. The optimization (Fig. 6) of the
43 codons of the 68 amino acids within the N-terminal
portion of EgD5D-34G/158G, EgD5M, improved substrate
conversion (Table 6). This improvement may relate to the
rate of translation. Recent reports suggest that sequence at
the beginning of a gene can influence translation, and the
mRNA structure at the 50 end of an mRNA can affect
protein levels [58, 59]. Next, we substituted the arginine
residue at position 347 with the serine which was identified
in our original PCR products. Surprisingly, this R347S
substitution in codon optimized EgD5M1 further improved
substrate conversion (Table 6). These data suggest that
some un-conserved amino acids among different D5
desaturases may be good targets for protein evolution to
generate improved enzymes. At this stage, the improved
EgD5D, both EgD5M and EgD5M1 should enable us to
engineer Yarrowia and other organisms to produce high
levels of ARA, EPA and DHA.
In conclusion, our studies suggest that the exact
sequences of the HPGG and HDASH motifs are not nec-
essary for the function of EgD5D. Several amino acids
within these two motifs can be changed individually, or
simultaneously, without significantly reducing the enzyme
activity or altering its substrate specificity. In some cases
such as EgD5D-36D, EgD5D-36S, and EgD5D-158G
mutants, the D5 desaturase activity can be improved. In
order to fully understand the function of EgD5D, the roles
of the HX(2, 3)HH and (H/Q)X(2, 3)HH motifs as well as the
un-conserved amino acids need to be studied in the future.
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